compounded semaglutide vs glp-1 Liraglutide Semaglutide: Comparing Weight Loss & Other Benefits Comparing Ozempic, Wegovy and Other

Description

Fitty Tip: Craving something sweet

Astrup, A, Carraro, R, Finer, N, et al

Wegovy and Ozempic, side-by-side A few caveats about the drugs follow, but keep in mind with the marketplace driving much of the thinking, and clinical experience evolving, there may be changes in store: Wegovy is FDA-approved for chronic weight loss management in adults 18 years of age or older with a BMI of 30 or BMI 27 and at least one medical condition related to obesity (e.g., diabetes, hypertension, etc.)

Eligible patients entered run-in phase where any OAD other than metformin were stopped and patients were prescribed glargine

For pipeline context and head-to-head insights, see Orforglipron vs Rybelsus for how next-generation oral options may compare in practice, and follow Orforglipron Clinical Trials for updated results and milestones